519 related articles for article (PubMed ID: 17341532)
1. Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial.
Shah SA; Sander S; Cios D; Lipeika J; Kluger J; White CM
Ann Pharmacother; 2007 Mar; 41(3):420-5. PubMed ID: 17341532
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic and blood pressure effects of the ephedra-containing TrimSpa thermogenic herbal compound in healthy volunteers.
Caron MF; Dore DD; Min B; Kluger J; Boguk I; White CM
Pharmacotherapy; 2006 Sep; 26(9):1241-6. PubMed ID: 16945045
[TBL] [Abstract][Full Text] [Related]
3. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials.
Rosenfeldt FL; Haas SJ; Krum H; Hadj A; Ng K; Leong JY; Watts GF
J Hum Hypertens; 2007 Apr; 21(4):297-306. PubMed ID: 17287847
[TBL] [Abstract][Full Text] [Related]
4. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine.
Slater SK; Nelson TD; Kabbouche MA; LeCates SL; Horn P; Segers A; Manning P; Powers SW; Hershey AD
Cephalalgia; 2011 Jun; 31(8):897-905. PubMed ID: 21586650
[TBL] [Abstract][Full Text] [Related]
6. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
7. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects.
Min B; Cios D; Kluger J; White CM
Pharmacotherapy; 2005 Dec; 25(12):1719-24. PubMed ID: 16305290
[TBL] [Abstract][Full Text] [Related]
8. Effects of short-term supplementation with coenzyme Q10 on myocardial protection during cardiac operations.
Taggart DP; Jenkins M; Hooper J; Hadjinikolas L; Kemp M; Hue D; Bennett G
Ann Thorac Surg; 1996 Mar; 61(3):829-33. PubMed ID: 8619701
[TBL] [Abstract][Full Text] [Related]
9. Effects of coenzyme Q10 supplementation on plasma adiponectin, interleukin-6, and tumor necrosis factor-alpha levels in men.
Gökbel H; Gergerlioğlu HS; Okudan N; Gül I; Büyükbaş S; Belviranli M
J Med Food; 2010 Feb; 13(1):216-8. PubMed ID: 20136458
[TBL] [Abstract][Full Text] [Related]
10. Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial.
Ikematsu H; Nakamura K; Harashima S; Fujii K; Fukutomi N
Regul Toxicol Pharmacol; 2006 Apr; 44(3):212-8. PubMed ID: 16431002
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
[TBL] [Abstract][Full Text] [Related]
12. Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans.
Hartigan-Go K; Bateman DN; Nyberg G; Mårtensson E; Thomas SH
Clin Pharmacol Ther; 1996 Nov; 60(5):543-53. PubMed ID: 8941027
[TBL] [Abstract][Full Text] [Related]
13. Investigating the effect of sotalol on the repolarization intervals in healthy young individuals.
Couderc JP; Zhou M; Sarapa N; Zareba W
J Electrocardiol; 2008; 41(6):595-602. PubMed ID: 18801493
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure and heart rate effects following a single dose of bitter orange.
Bui LT; Nguyen DT; Ambrose PJ
Ann Pharmacother; 2006 Jan; 40(1):53-7. PubMed ID: 16317106
[TBL] [Abstract][Full Text] [Related]
15. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure.
Sander S; Coleman CI; Patel AA; Kluger J; White CM
J Card Fail; 2006 Aug; 12(6):464-72. PubMed ID: 16911914
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effect of almotriptan in treated hypertensive patients.
Fleishaker JC; McEnroe JD; Azie NE; Francom SF; Carel BJ
Clin Pharmacol Ther; 2002 Mar; 71(3):169-75. PubMed ID: 11907491
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.
Wang Z; Grasela DM; Krishna G
Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
Marbury TC; Jin B; Panebianco D; Murphy MG; Sun H; Evans JK; Han TH; Constanzer ML; Dru J; Shadle CR
Anesth Analg; 2009 Aug; 109(2):418-25. PubMed ID: 19608812
[TBL] [Abstract][Full Text] [Related]
19. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system.
Liu ZX; Artmann C
Altern Ther Health Med; 2009; 15(2):42-6. PubMed ID: 19284181
[TBL] [Abstract][Full Text] [Related]
20. Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates.
Cicero AF; Derosa G; Miconi A; Laghi L; Nascetti S; Gaddi A
Biomed Pharmacother; 2005 Jul; 59(6):312-7. PubMed ID: 15932792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
